CD40LG and COVID-19: Our initial goal was to determine the main B cell epitopes recognized by patients and compare them with previous studies performed in Asia, Europe, or USA patients1–11, to see if distributions of IgM and IgG epitopes could explain the various COVID-19 clinical profiles.